인디애나폴리스의 활력

BioCrossroads, 인디애나주 생명과학 부문의 협력과 성장 촉진

Since 2002, BioCrossroads has worked to catalyze innovation and collaboration within Indiana’s life sciences sector. The sector has grown at a remarkable pace and has generated billions of dollars in revenue for the state with $79 billion in economic impact in 2021. BioCrossroads plays a critical role by convening academic, philanthropic, and cross-sector employer partners, enhancing research development, and working to attract life sciences businesses, innovation, and talent to Indiana.  

This unique collaborative approach has proven to be successful in times of need. At the onset of the COVID-19 pandemic, BioCrossroads played a key role convening Indiana’s life science and healthcare partners troubleshoot COVID testing, vaccine development and deployment, and other needs for Indiana residents.  

The Richard M. Fairbanks Foundation has awarded $11.5 million to BioCrossroads since 2003 to advance the economic vitality of Indianapolis. 

Additional Posts

건강

Tobacco 21 and the Military—Old Enough to Fight but Not Old Enough to Smoke?

Alex Cohen is the Director of Learning and Evaluation for the Richard M. Fairbanks Foundation. Smoking remains the leading cause of preventable death nationwide. In Indiana, which has among the highest smoking rates in the U.S., an estimated 11,000 people die each year from smoking. While smoking-related illnesses generally occur in older ages, smoking starts […]

READ MORE
건강

New Indianapolis Star Series about the Opioid Epidemic Will Highlight the Facts and Shine a Spotlight on Potential Solutions

Claire Fiddian-Green is the President & CEO of the Richard M. Fairbanks Foundation. The opioid epidemic has received a lot of attention in Indiana, and for good reason. Drug overdose deaths – which are currently being driven by misuse of opioids, including prescription painkillers, heroin and synthetic opioids like fentanyl – resulted in the death […]

READ MORE